As proving MAE remains huge undertaking, Advent snags Forescout at a discount

While the highly anticipated MAE trial is called off, Advent's revised agreement for Forescout narrows from $1.9bn to to $1.43bn.

DealsNorth AmericaUSTMTCoronavirusFeaturedTop Stories